Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Stroke patients try intensive Tech-Powered rehab in swiss study

NCT ID NCT07427511

Disease control Sponsor: Centre Hospitalier Universitaire Vaudois Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether a high-dose, high-intensity neurorehabilitation program using digital devices (MindMotion GO, Izar) is feasible for stroke patients. 120 adults with stroke will train about one hour per day, five days a week, across inpatient and home settings. The goal is to see if patients can stick with the program and find it helpful, while also measuring improvements in motor function and daily life.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
high-dose, high-intensity neurorehabilitation using digital therapeutic devices (MindMotion GO, Izar)
What this could lead to
If successful, this could show that intensive, technology-assisted rehab is feasible in real-world settings and may improve motor recovery after stroke.
What could go wrong
This is an early feasibility study with only 120 participants and no control group, so results may not prove effectiveness. The high training dose may be hard for some patients to maintain.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 120 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Feb 2026

An estimate. Start dates often move.

Expected to finish

May 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 85 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Adults aged 18-85 years. * Confirmed diagnosis of stroke (ischemic or hemorrhagic) \>7 days ago * Be able to sit unassisted * Able and willing to give informed consent * Have motor difficulties of the Upper Extremity and/or Lower Extremity * Willing to commit to program length \& daily training dose * Willing to have assessments at start and end of program * Signed informed consent Exclusion Criteria: * Severe cognitive impairment * Uncontrolled seizure disorder or epilepsy - clinician's judgement) * Any medical condition that would compromise their safety (inability to communicate, vision or hearing impairment, heart condition that limits participation in exercise) and tolerability (cardiac contraindications) * Pain that would limit rehabilitation dose * Severe apraxia * Severe memory disorder * Severe hemispatial neglect * Plegia of the affected limb

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Stroke are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

stroke disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Stroke

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    5 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Centre hospitalier universitaire Vaudois

    RECRUITING

    Lausanne, Canton of Vaud, 1011, Switzerland

  • Klinik Valens

    RECRUITING

    Valens, Canton of St. Gallen, 7317, Switzerland

  • Lake Lucerne Institute

    NOT_YET_RECRUITING

    Vitznau, Canton of Lucerne, 6354, Switzerland

  • Swiss Réhabilitation Sàrl

    RECRUITING

    Sullens, Canton of Vaud, 1036, Switzerland

  • Universitätspital Zürich

    NOT_YET_RECRUITING

    Zurich, Canton of Zurich, 8006, Switzerland

More trials for these conditions

Other studies related to the condition(s) this trial covers.